🇺🇸 NAs in United States
39 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 39
Most-reported reactions
- Death — 14 reports (35.9%)
- Diarrhoea — 4 reports (10.26%)
- Pneumonia — 4 reports (10.26%)
- Arthralgia — 3 reports (7.69%)
- Fatigue — 3 reports (7.69%)
- Nausea — 3 reports (7.69%)
- Abdominal Pain — 2 reports (5.13%)
- Back Pain — 2 reports (5.13%)
- Breast Cancer — 2 reports (5.13%)
- Bronchitis — 2 reports (5.13%)
Other Respiratory approved in United States
Frequently asked questions
Is NAs approved in United States?
NAs does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for NAs in United States?
Beijing 302 Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.